Literature DB >> 26542100

Imaging mass spectrometry in drug discovery and development.

Stacey R Oppenheimer1, Angela Y Wehr2.   

Abstract

Keywords:  3D imaging; MS imaging; MSI; drug development; drug discovery; drug distribution; metabolite distribution

Mesh：

Substances：

Year:  2015        PMID： 26542100     DOI： 10.4155/bio.15.202

Source DB:  PubMed          Journal:  Bioanalysis        ISSN： 1757-6180            Impact factor:   2.681


× No keyword cloud information.
  4 in total

Review 1.  Current status and future prospects for enabling chemistry technology in the drug discovery process.

Authors:  Stevan W Djuric; Charles W Hutchins; Nari N Talaty
Journal:  F1000Res       Date:  2016-09-30

2.  Effects of notoginseng leaf triterpenes on small molecule metabolism after cerebral ischemia/reperfusion injury assessed using MALDI-MS imaging.

Authors:  Lei Wang; Ting Zhu; Hui-Bo Xu; Xiao-Ping Pu; Xin Zhao; Fang Tian; Tao Ding; Gui-Bo Sun; Xiao-Bo Sun
Journal:  Ann Transl Med       Date:  2021-02

3.  (S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats.

Authors:  Wan Li; Huihui Liu; Hanjie Jiang; Chen Wang; Yongfei Guo; Yi Sun; Xin Zhao; Xin Xiong; Xianhua Zhang; Ke Zhang; Zongxiu Nie; Xiaoping Pu
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

4.  3-O-Acetyl-11-keto- β -boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma.

Authors:  Wan Li; Liwen Ren; Xiangjin Zheng; Jinyi Liu; Jinhua Wang; Tengfei Ji; Guanhua Du
Journal:  Acta Pharm Sin B       Date:  2020-01-10       Impact factor: 11.413
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.